# A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia

> **NCT02008773** · PHASE2 · COMPLETED · sponsor: **Indiana University** · enrollment: 170 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Valacyclovir HCI 500 mg tablets
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02008773
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-26
- **Primary completion:** 2017-06-20
- **Final completion:** 2017-06-20
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2019-01-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02008773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02008773, "A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02008773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*